These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2960841)

  • 1. Heterogeneity in vasorelaxant effects of alpha-human atrial natriuretic polypeptide in the dog.
    Ishikawa N; Hayakawa A; Uematsu T; Nakashima M
    Jpn J Pharmacol; 1987 Aug; 44(4):515-8. PubMed ID: 2960841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors mediating a regional difference in vasorelaxing effects of human natriuretic polypeptide in dogs.
    Kawanishi M; Hayakawa A; Taki K; Shimada Y; Ishikawa N
    Arch Int Pharmacodyn Ther; 1989; 298():198-209. PubMed ID: 2527019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of atrial natriuretic peptide (ANP) on dog cerebral arteries: evidence that neurogenic relaxation is not mediated by release of ANP.
    Okamura T; Inoue S; Toda N
    Br J Pharmacol; 1989 Aug; 97(4):1258-64. PubMed ID: 2529017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide.
    Kawai Y; Ohhashi T
    Can J Physiol Pharmacol; 1989 Apr; 67(4):326-30. PubMed ID: 2527081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of nitrovasodilators and atrial natriuretic peptide in isolated dog coronary arteries.
    Matsumoto T; Okamura T; Kinoshita M; Toda N
    Eur J Pharmacol; 1993 Jun; 237(1):31-7. PubMed ID: 8395391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in ANP responsiveness of normal and hypertensive porcine intrapulmonary arteries during maturation.
    Matsushita T; Hislop AA; Boels PJ; Deutsch J; Haworth SG
    Pediatr Res; 1999 Oct; 46(4):411-8. PubMed ID: 10509361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of monkey, rabbit and dog internal carotid arteries to atrial natriuretic factor.
    Kawai Y; Ohhashi T
    Experientia; 1987 May; 43(5):568-70. PubMed ID: 2953624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of atrial natriuretic peptide on human isolated resistance arteries.
    Hughes AD; Nielsen H; Sever PS
    Br J Pharmacol; 1989 Aug; 97(4):1027-30. PubMed ID: 2529013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro.
    Jansen TL; Morice AH; Brown MJ
    Br J Pharmacol; 1987 Jul; 91(3):687-91. PubMed ID: 2955844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasorelaxant effect of atrial natriuretic peptide in the frog.
    Chiu KW; Lee YC; Pang PK
    Gen Comp Endocrinol; 1990 Apr; 78(1):42-7. PubMed ID: 2139619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.
    Toda N
    Br J Pharmacol; 1984 Oct; 83(2):399-408. PubMed ID: 6435709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
    Matsumoto T; Wada A; Tsutamoto T; Omura T; Yokohama H; Ohnishi M; Nakae I; Takahashi M; Kinoshita M
    Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism underlying relaxations caused by prostaglandins and thromboxane A2 analog in isolated dog arteries.
    Toda N; Inoue S; Okamura T; Okunishi H
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):354-62. PubMed ID: 2452930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes impairs the atrial natriuretic peptide relaxant action mediated by potassium channels and prostacyclin in the rabbit renal artery.
    Marrachelli VG; Centeno JM; Miranda I; Castelló-Ruiz M; Burguete MC; Jover-Mengual T; Salom JB; Torregrosa G; Miranda FJ; Alborch E
    Pharmacol Res; 2012 Nov; 66(5):392-400. PubMed ID: 22898325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasorelaxant effects of and receptors for atrial natriuretic peptides in the mesenteric artery and aorta of the rat.
    St-Louis J; Schiffrin EL
    Can J Physiol Pharmacol; 1988 Jul; 66(7):951-6. PubMed ID: 2850846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasorelaxant effects of atrial peptide II on isolated human pulmonary muscle preparations.
    Labat C; Norel X; Benveniste J; Brink C
    Eur J Pharmacol; 1988 Jun; 150(3):397-400. PubMed ID: 2970976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-removal decreases relaxations of canine coronary arteries caused by beta-adrenergic agonists and adenosine.
    Rubanyi G; Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7(1):139-44. PubMed ID: 2580134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator responses to alpha-human-atrial natriuretic peptide in isolated omental and pulmonary arteries from rabbit and man.
    Lindberg F; Andersson KE
    Acta Physiol Scand; 1988 Nov; 134(3):391-7. PubMed ID: 2976241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of relaxation induced by atrial natriuretic peptide in the porcine renal artery.
    Seguchi H; Nishimura J; Toyofuku K; Kobayashi S; Kumazawa J; Kanaide H
    Br J Pharmacol; 1996 May; 118(2):343-51. PubMed ID: 8735636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular responses of isolated, perfused canine femoral arteries and veins to vasoactive substances.
    Kawai K; Chiba S
    Jpn J Pharmacol; 1986 Aug; 41(4):537-40. PubMed ID: 3464791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.